Back
IDEXX Laboratories Quote, Financials, Valuation and Earnings
Buy
63
IDXX
IDEXX Laboratories
Last Price:
503.98
Seasonality Move:
8.7%
7 Day Trial
ALL ACCESS PASS
$
7
IDEXX Laboratories Price Quote
$503.98
-0.02 (-0.42%)
(Updated: June 15, 2024 at 5:35 AM ET)
IDEXX Laboratories Key Stats
Buy
63
IDEXX Laboratories (IDXX)
is a Buy
Day range:
$500.52 - $508.90
52-week range:
$372.50 - $583.39
Dividend yield:
0%
P/E ratio:
50.10
P/S ratio:
11.36
P/B ratio:
26.53%
Volume:
384.3K
Avg. volume:
503.4K
1-year change:
7.93%
Market cap:
$41.6B
Revenue:
$3.7B
EPS:
$10.33
How Much Does IDEXX Laboratories Make?
-
How Much Are IDEXX Laboratories's Sales Annually?
IDXX Revenues are $3.7B -
How Much Profit Does IDEXX Laboratories's Make A Year?
IDXX net income is $845M
Is IDEXX Laboratories Growing As A Company?
-
What Is IDEXX Laboratories's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.07% -
What Is IDEXX Laboratories's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.1%
IDEXX Laboratories Stock Price Performance
-
Did IDEXX Laboratories Stock Go Up Last Month?
IDEXX Laboratories share price went down by -3.28% last month -
Did IDXX's Share Price Rise Over The Last Year?
IDXX share price rose by 7.93% over the past 1 year
What Is IDEXX Laboratories 52-Week High & Low?
-
What Is IDEXX Laboratories’s 52-Week High Share Price?
IDEXX Laboratories has traded as high as $583.39 over the past 52 weeks -
What Is IDEXX Laboratories’s 52-Week Low Share Price?
IDEXX Laboratories has traded as low as $372.50 over the past 52 weeks
IDEXX Laboratories Price To Free Cash Flow
-
Is IDEXX Laboratories Stock Overvalued?
IDEXX Laboratories is trading at a price to free cash flow ratio of 53.11 -
Is IDEXX Laboratories Stock Undervalued?
IDEXX Laboratories EV to Free Cash Flow ratio is 52.93 -
What Is IDEXX Laboratories’s Price Earnings Growth Ratio?
IDXX PEG ratio is 2.01 -
Is IDEXX Laboratories Trading At A Premium To Earnings?
IDEXX Laboratories EV to EBIT ratio is 37.48
Is It Risky To Buy IDEXX Laboratories?
-
How Much Debt Does IDEXX Laboratories Have?
Total long term debt quarterly is $945.8M -
How Much Cash Does IDEXX Laboratories Have?
Cash and short term investments quarterly total is $397.4M -
What Is IDEXX Laboratories’s Book Value Per Share?
Book value per share is 18.93
Is IDEXX Laboratories Cash Flow Positive?
-
What Is IDXX Cash Flow From Operations?
Cash flow from operations (TTM) is $921.2M -
What Is IDEXX Laboratories’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$440M -
What Is IDEXX Laboratories’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$192.7M
IDEXX Laboratories Return On Invested Capital
-
Is Management Doing A Good Job?
IDXX return on invested capital is 37.89% -
What Is IDEXX Laboratories Return On Assets?
ROA measures how assets are converting to revenues and is 28.17% -
What Is IDXX Return On Equity?
ROE is a measure of profitability and is 68.93%
IDEXX Laboratories Earnings Date & Stock Price
-
What Is IDEXX Laboratories's Stock Price Today?
A single share of IDXX can be purchased today for 504.00 -
What Is IDEXX Laboratories’s Stock Symbol?
IDEXX Laboratories trades on the nasdaq under the ticker symbol: IDXX -
When Is IDEXX Laboratories’s Next Earnings Date?
The next quarterly earnings date for IDEXX Laboratories is scheduled on August 6, 2024 -
When Is IDXX's next ex-dividend date?
IDEXX Laboratories's next ex-dividend date is June 16, 2024 -
How To Buy IDEXX Laboratories Stock?
You can buy IDEXX Laboratories shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
IDEXX Laboratories Competitors
-
Who Are IDEXX Laboratories's Competitors?
Below is a list of companies who compete with IDEXX Laboratories or are related in some way:
IDEXX Laboratories Dividend Yield
Data Unavailable
IDEXX Laboratories Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 10.2% | 4.79% |
| Revenue: | 7.1% | -0.18% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 4 |
| Sell Recommendations: | 0 |
| Price Target: | 565.05 |
| Upside from Last Price: | 12.11% |